Dr. Patrick Pfeffer

LIMAA develops a fully automated tissue preserving end-to-end histopathology platform for clinical use. This first of its kind platform allows to analyze entire tissue biospecimens in 2D and 3D without embedding or slicing while the tissue is not consumed. Preserved tissue samples are used for downstream applications leading to the unique opportunity to integrate multiplex biomarker visualization of entire tissue samples, genomics and AI guided decision making in every routine sample - no matter what sample size.

PIUR IMAGING, an Austrian medtech company, which is active in the field of diagnostic ultrasound imaging and is specialized in acquisition and visualization of 3D ultrasound images. PIUR IMAGINGs vision is it to provide access to affordable high-quality healthcare through AI-driven tomographic ultrasound solutions – everywhere! PIUR´s tomographic ultrasound solution PIUR tUS Infinity turns any standard ultrasound system into a tomographic 3D imaging device, enabling true AI in ultrasound. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated. While standard ultrasound requires on-the-spot assessment of the images, PIUR´s 3D ultrasound volumes of entire structures or organs allow retrospective diagnosis at any time. In combination with smart analysis tools, explicitly designed for the evaluation of thyroid and nodules, thyroid analysis becomes less operator-dependent and diagnostic workflows can be optimized. PIUR tUS Infinity is the only vendor-independent tomographic 3D ultrasound solution, designed to improve thyroid diagnostics.

Autolomous is a company founded by Cell and Gene Therapy (CGT)- and software development experts, who have combined their skills to deliver elegant, seamless and agile solutions to the CGT sector. Autolomous will deliver the digital solutions necessary for CGT to achieve scalability, allowing more patients to benefit from these life changing therapies. The company is creating a portfolio of software solutions (AutoloMATE-solution platform), from electronic Batch Manufacturing Records (eBMR) to enabling the scheduling of the patient blood collections at hospital; the transport of those cells to the manufacturing facilities; enhancing traceability throughout the manufacturing process; supporting compliance with current and future regulatory requirements; expediting the drug product release; and the scheduled delivery of the patient-specific medicine to the hospital. Our software will enable increased automation of these processes, reducing the risk of errors and ensuring that the correct product is returned to the right patient. AutoloMATE has been architected with agility, flexibility and adaptability in mind both for our customers for customization but also for our partners to integrate with our platform to create an end-to-end digital ecosystem. We’re looking for new team members. Are you a forward-thinking-digitally-minded individual? Do you want to be part of a meaningful and value-orientated company? Get in touch!

XO Life stands for ✅ a state-of-the-art platform solution for long-term Patient Insights from the real world ✅ real time information exchange between patients and pharma ✅ a all-in-one platform to be used across all treatments and indications We are a young and dynamic eHealth company setting a new standard patient data collection through scientifically based questionnaires across all treatments and medications. XO Life helps the pharmaceutical industry to better understand its patients. Our goal is to make digital treatment monitoring and patient feedback the gold standard in R&D, marketing and sales, while ensuring the highest data protection and security standards. ➡️ Join us in shaping the future of patient centered medical data collection and learn more at:

The Neteera System automates contactless patient and resident monitoring by measuring and tracking vital signs and activity metrics without wires, wearables, or patient compliance. Ambient radar sensor technology, combined with sophisticated algorithms, provides accurate, real-time patient insights. Our innovative monitoring and alert platform enhances patient care and comfort without cameras, microphones, clothing removal, or staff activation. Caregivers can stay ahead of patient conditions with smart alerts customized to desired thresholds and baseline deviations. Designed for most healthcare settings, Neteera technology is FDA-cleared and CE-certified by NB 2797. Simple, accurate, and secure—Neteera empowers healthcare providers to elevate patient care. Neteera was founded in 2015 by a group of hi-tech veteran executives, including Isaac Litman, the CEO of Mobileye (NYSE: MBLY) Aftermarket.

Scopio Labs is transforming cell morphology analysis, offering fully digital applications, platforms, and diagnostic support that enhance clinical workflows. By assisting lab experts with fast, early, and accurate detection and diagnosis of disease, Scopio expedites patients access to life-saving treatments. .

Ceidos developed the C-Netics to fully automate cell expansion monitoring in a closed system. This ensures better outcomes and reduces the process’ costs as contamination risk is prevented and manual handling is drastically reduced.

neurocare is innovating mental health and performance by personalizing therapy following a detailed assessment. neurocare’s objective, measurable and effective approach is based on our natural ability to learn (neuroplasticity) and technology to speed up the learning (neuromodulation). neurocare helps individuals to improve their self regulation and hence is a sustainable solution. The neurocare group provides a Digital Therapy Platform and Teletherapy and our vertical integration and know-how in Science, Neuromodulation Technology and clinical SOP’s is unique.

Cardiolyse is a cloud ECG & HRV analytics platform, that enables real-time remote heart health monitoring, providing plain personalized reports, detection and up to two months data-based prognosis on dangerous heart events. Our groundbreaking ECG analytic technology enables people 45+, their families, healthcare providers and insurance companies: - To get in-depth snapshot of cardiovascular system state and to monitor its trend; - Allows making six-month forecast of serious cardiovascular events; - To learn how current lifestyle is interconnected with heart conditions.

We help Parkinsons patients to maintain their mobility and autonomy

The munevo GmbH team created munevo DRIVE to provide an intuitive, comfortable electric wheelchair operation option for people with significant mobility impairments. munevo’s mission? Empowering people! Smartglasses transmit the users head movements into digital signals, which enables them to operate their electric wheelchair hands-free. munevo DRIVE is compatible with various add-ons such as mobile devices, a robotic arm and smart home systems. #empoweringpeople

𝒎𝑹𝑵𝑨-𝒃𝒂𝒔𝒆𝒅 𝒅𝒊𝒂𝒈𝒏𝒐𝒔𝒕𝒊𝒄𝒔 𝒂𝒏𝒅 𝒕𝒉𝒆𝒓𝒂𝒑𝒆𝒖𝒕𝒊𝒄𝒔 𝒇𝒐𝒓 𝒎𝒆𝒕𝒂𝒃𝒐𝒍𝒊𝒄 𝒅𝒊𝒔𝒆𝒂𝒔𝒆𝒔 We are pioneering the use of the mRNAs of the subcutaneous adipose tissue (SAT) for medical purposes. The SAT is a metabolically highly active organ and is directly involved in the development of metabolic diseases. Its activity is controlled by special mRNAs. These mRNAs provide a highly effective new starting point for the diagnosis and therapy of these diseases. Through our innovations, we can easily analyze the complex mRNA-patterns of a patients SAT. We have developed diagnostic tests for the personalized therapy-planning of metabolic patients. In the future, we will additionally target mRNA-based personalized therapy concepts for the recovery of SAT. We develop our patented products together with renowned university partners.

BOCAhealth is the story of two medical doctors best friends that brought to reality the idea that heart failure and kidney disease patients need to have a better way to be monitored. From the experience Alessandro´s father experience, a patient with heart failure suffering from congestion by excessive body water, BOCAhealth was developed as the solution for monitoring, predicting and preventing cardiovascular events caused by body water . This thanks to a simple hardware and a powerful software driven by artificial intelligence.

VisionHealth develops and implements innovative digital healthcare solutions at the highest level, enabling real progress and improvement of therapy standards for patients in a networked world. The pioneers in the field of digital respiratory treatments bring together excellence in the areas of respiratory therapy, digitalization, regulations and marketing to create unique interdisciplinary, international expertise. The German start-up company makes use of an excellent infrastructure and direct links to universities and experts. The managing directors are recognized specialists in pneumology and respiration and have many years of outstanding experience in their fields. The dynamic team has made a name for itself in respiratory medicine, IT and the market. https://visionhealth.gmbh/impressum/

LIMAA develops a fully automated tissue preserving end-to-end histopathology platform for clinical use. This first of its kind platform allows to analyze entire tissue biospecimens in 2D and 3D without embedding or slicing while the tissue is not consumed. Preserved tissue samples are used for downstream applications leading to the unique opportunity to integrate multiplex biomarker visualization of entire tissue samples, genomics and AI guided decision making in every routine sample - no matter what sample size.

BAIBYS™ revolutionizes fertility treatment with cutting-edge AI and micro-robotics. Our autonomous system transforms sperm selection for IVF, delivering unparalleled efficiency and precision using high magnification. By automating the process to a few minutes (including the physical pick-up and relocation into target droplets), we dramatically reduce time and costs while adhering to WHO morphology and motility criteria. The user-friendly console and disposable cartridges streamline laboratory workflows, boosting clinic productivity and revenue. Our innovation will elevate IVF success rates, minimize birth defects, and alleviate the economic strain on healthcare systems. By freeing up embryologists and making IVF more accessible globally, BAIBYS™ opens doors for countless families dreaming of healthy babies. Team up with BAIBYS™ and be part of a groundbreaking solution that not only disrupts the fertility market but also creates a profound social impact. Join us in shaping the future of reproductive medicine and helping more families experience the joy of parenthood.

PIUR IMAGING, an Austrian medtech company, which is active in the field of diagnostic ultrasound imaging and is specialized in acquisition and visualization of 3D ultrasound images. PIUR IMAGINGs vision is it to provide access to affordable high-quality healthcare through AI-driven tomographic ultrasound solutions – everywhere! PIUR´s tomographic ultrasound solution PIUR tUS Infinity turns any standard ultrasound system into a tomographic 3D imaging device, enabling true AI in ultrasound. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated. While standard ultrasound requires on-the-spot assessment of the images, PIUR´s 3D ultrasound volumes of entire structures or organs allow retrospective diagnosis at any time. In combination with smart analysis tools, explicitly designed for the evaluation of thyroid and nodules, thyroid analysis becomes less operator-dependent and diagnostic workflows can be optimized. PIUR tUS Infinity is the only vendor-independent tomographic 3D ultrasound solution, designed to improve thyroid diagnostics.

We are building a pan-European brand to become the leading driving force for artificial intelligence in medicine.

At Caresyntax, we are dedicated to making surgery safer and smarter. Our mission is to converge AI-powered software, devices, and clinical services to help our customers improve surgical outcomes. Our platform, an enterprise-grade surgical intelligence system, is vendor-neutral and equipped with proprietary software, hardware, and advanced AI capabilities. It can ingest and analyze data throughout the surgical workflow, including EMR, video, audio, image, device data, financial and outcomes data, and clinical and operational metrics to capture a complete picture of the surgical pathway. The platform generates insights across the entire continuum of care—before the procedure with surgical workflow optimization, during surgery with real-time clinically relevant support tools, and post procedure with clinical safety modules. The platform also produces data analytics and insights for medical device companies, insurers, and other ecosystem players to innovate and drive the future of healthcare delivery. Headquartered in the US in San Francisco and internationally in Berlin, Caresyntax software is used in over 4,200 ORs globally and aids surgical teams in over 3 million procedures annually. To learn more about how we’re transforming surgical care, visit us at www.caresyntax.com.